← Back to Analyst Consensus 
IRD Buy
Opus Genetics, Inc.
Current Price —
Implied Upside —
Analysts 22
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 4 reiterations from 3 firms
Next Earnings
Nov 10, 2026 (15 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 22, 2026 | Chardan Capital | maintain | Buy → Buy | — | 47% |
| Oct 16, 2026 | Citizens | reiterate | Market Outperform → Market Outperform | — | 47% |
| Oct 6, 2026 | Jones Trading | maintain | Buy → Buy | — | 50% |
| Oct 2, 2026 | Chardan Capital | maintain | Buy → Buy | — | 47% |
| Sep 10, 2026 | Wedbush | maintain | Outperform → Outperform | — | 58% |
| Sep 9, 2026 | Oppenheimer | maintain | Outperform → Outperform | — | 52% |
| Sep 9, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Sep 9, 2026 | BTIG | reiterate | Buy → Buy | — | 52% |
| Sep 9, 2026 | Chardan Capital | maintain | Buy → Buy | — | 47% |
| Aug 7, 2026 | RBC Capital | maintain | Outperform → Outperform | — | 55% |
| Jul 29, 2026 | TD Cowen | initiate | — → Buy | — | 54% |
| Jul 6, 2026 | Chardan Capital | maintain | Buy → Buy | — | 47% |
| Jul 6, 2026 | BTIG | reiterate | Buy → Buy | — | 52% |
| Jun 18, 2026 | Chardan Capital | maintain | Buy → Buy | — | 47% |
| Jun 17, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Jun 16, 2026 | BTIG | reiterate | Buy → Buy | — | 52% |
| Jun 15, 2026 | Citizens | reiterate | Market Outperform → Market Outperform | — | 47% |
| Jun 4, 2026 | Guggenheim | initiate | — → Buy | — | 52% |
| May 21, 2026 | Leerink Partners | initiate | — → Outperform | — | 51% |
| May 13, 2026 | Citizens | maintain | Market Outperform → Market Outperform | — | 47% |
| Apr 28, 2026 | Citizens | initiate | — → Market Outperform | — | 47% |
| Mar 30, 2026 | Cantor Fitzgerald | initiate | — → Overweight | — | 50% |
| Mar 16, 2026 | Oppenheimer | initiate | — → Outperform | — | 52% |
| Mar 12, 2026 | Wedbush | maintain | Outperform → Outperform | — | 58% |
| Mar 12, 2026 | Chardan Capital | maintain | Buy → Buy | — | 47% |
| Mar 2, 2026 | BTIG | maintain | Buy → Buy | — | 52% |
| Jan 28, 2026 | BTIG | reiterate | Buy → Buy | $7 | 52% |
| Jan 20, 2026 | BTIG | initiate | — → Buy | $7 | 52% |
| Dec 10, 2025 | B. Riley Securities | initiate | — → Buy | $9 | 55% |
| Nov 25, 2025 | Piper Sandler | initiate | — → Overweight | $7 | 54% |
| Nov 13, 2025 | Chardan Capital | maintain | Buy → Buy | $9 | 47% |
| Nov 7, 2025 | Chardan Capital | maintain | Buy → Buy | $9 | 47% |
| Oct 29, 2025 | Wedbush | initiate | — → Outperform | $8 | 58% |
| Oct 16, 2025 | Chardan Capital | initiate | — → Buy | $9 | 47% |
| Jun 27, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $8 | 44% |
| Jun 17, 2025 | LUCID CAPITAL MARKETS | initiate | — → Buy | $5 | 32% |
| Apr 11, 2025 | Craig-Hallum | initiate | — → Buy | $6 | 54% |
| Apr 1, 2025 | Jones Trading | maintain | Buy → Buy | $8 | 50% |
| Apr 1, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $8 | 44% |
| Feb 19, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $8 | 44% |
| Dec 12, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $8 | 44% |
| Oct 23, 2024 | Canaccord Genuity | maintain | Buy → Buy | $10 | 48% |
| Aug 15, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $18 | 44% |
| Aug 14, 2024 | Canaccord Genuity | maintain | Buy → Buy | $18 | 48% |
| May 13, 2024 | Canaccord Genuity | maintain | Buy → Buy | $18 | 48% |
| May 13, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $20 | 44% |
Price Target Trend
Jul 19, 2026 Oct 26, 2026
EPS Estimates
+1y —
0q —
0y —
+1q —
Cross-Platform Signals
No cross-platform signals in the last 90 days